Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tennvall

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Palliation of multiple bone metastases from prostatic carcinoma with strontium-89J Tennvall, L Darte, R Lundgren, et al.
Acta Radiologica. Oncology|January 1, 1985
Prognostic factors of papillary, follicular and medullary carcinomas of the thyroid gland. Retrospective multivariate analysis of 216 patients with a median follow-up of 11 yearsJ Tennvall, A Biörklund, T Möller, et al.
Cancer|April 1, 1986
Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-upJ Tennvall, A Biörklund, T Möller, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1992
Radiotherapy for unresectable endocrine pancreatic carcinomasJ Tennvall, O Ljungberg, B Ahrén, et al.
Urology|December 31, 1997
Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapyI Malmberg, U Persson, A Ask, et al.
Medical & Biological Engineering & Computing|September 1, 1994
Radio-immunotherapy dosimetry with special emphasis on SPECT quantification and extracorporeal immuno-adsorptionS E Strand, M Ljungberg, J Tennvall, et al.
Progress in Nuclear Medicine|January 1, 1984
Studies of NMR-relaxation-times in malignant tumours and normal tissues of the human thyroid glandJ Tennvall, A Biörklund, T Möller, et al.
Cancer|December 24, 1997
Improving tumor-to-normal-tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin-biotin concept: development of a new treatment strategy applied to monoclonal antibodies murine L6 and chimeric BR96J Tennvall, M Garkavij, J Chen, et al.
Archives of Otolaryngology--Head & Neck Surgery|August 1, 1993
DNA analysis as a predictor of the outcome of induction chemotherapy in advanced head and neck carcinomasJ Tennvall, J Wennerberg, H Anderson, et al.
Acta Oto-Laryngologica|March 1, 1993
T3N0 glottic carcinoma: DNA S-phase as a predictor of the outcome after radiotherapyJ Tennvall, J Wennerberg, R Willén, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Palliation of multiple bone metastases from prostatic carcinoma with strontium-89J Tennvall, L Darte, R Lundgren, et al.
Acta Radiologica. Oncology|January 1, 1985
Prognostic factors of papillary, follicular and medullary carcinomas of the thyroid gland. Retrospective multivariate analysis of 216 patients with a median follow-up of 11 yearsJ Tennvall, A Biörklund, T Möller, et al.
Cancer|April 1, 1986
Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-upJ Tennvall, A Biörklund, T Möller, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1992
Radiotherapy for unresectable endocrine pancreatic carcinomasJ Tennvall, O Ljungberg, B Ahrén, et al.
Urology|December 31, 1997
Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapyI Malmberg, U Persson, A Ask, et al.
Medical & Biological Engineering & Computing|September 1, 1994
Radio-immunotherapy dosimetry with special emphasis on SPECT quantification and extracorporeal immuno-adsorptionS E Strand, M Ljungberg, J Tennvall, et al.
Progress in Nuclear Medicine|January 1, 1984
Studies of NMR-relaxation-times in malignant tumours and normal tissues of the human thyroid glandJ Tennvall, A Biörklund, T Möller, et al.
Cancer|December 24, 1997
Improving tumor-to-normal-tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin-biotin concept: development of a new treatment strategy applied to monoclonal antibodies murine L6 and chimeric BR96J Tennvall, M Garkavij, J Chen, et al.
Archives of Otolaryngology--Head & Neck Surgery|August 1, 1993
DNA analysis as a predictor of the outcome of induction chemotherapy in advanced head and neck carcinomasJ Tennvall, J Wennerberg, H Anderson, et al.
Acta Oto-Laryngologica|March 1, 1993
T3N0 glottic carcinoma: DNA S-phase as a predictor of the outcome after radiotherapyJ Tennvall, J Wennerberg, R Willén, et al.
Pageof 7